Popular searches: AAPL TSLA NVDA MSFT GOOGL

BIO Stock Price Prediction 2026

Bio-Rad Laboratories, Inc.Class A

$278.36
$-0.39 (-0.14%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: April 1, 2026

BIO Price Forecast 2026: Our AI models project that BIO stock will fall to approximately $267.23 by 2026. This represents a potential 4.0% contraction from the current trading price of $278.36. The overall market sentiment for BIO is currently neutral, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading at a P/E ratio of 10.0, with its most recent quarterly earnings growing by -0.8%. BIO shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2026 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a uptrend phase. The Relative Strength Index (RSI) is currently 56.9, which suggests the stock is trading in a neutral range. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2026 predicted target.

🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • TTM Squeeze ON for 2 days - volatility compression
  • MACD bullish crossover - upward momentum
  • Price near resistance at $281.62
MACD: Bullish | Volume: Neutral
Fair Value Estimate
-7.7% Overvalued
Fair Value: $257.00 (Current: $278.36)

Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.

PEG Ratio
2.13
Expensive
Current P/E
32.79
Fair P/E
30.27
Earnings Growth
15.4%
📉

Volume Trend: Neutral

Selling Pressure Present - Distribution pattern observed

Chaikin Money Flow (CMF): -0.022
Money Flow Index (MFI): 63.8

Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.

Options Analysis: 1-Year Target Strategy

Score: 0/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

STRONG SELL SIGNAL - Massively overpriced, excellent premium selling opportunity
Growth Target (1Y)
$320.50
+1.2% upside
Best Strike Found
$330.00
Exp: March 20, 2026, midnight
Call Premium
$20.00
6.3% of stock price
Breakeven Price
$350.00
⚠ Above target
Implied Probability
48.2%
Market's confidence
Value Score
-100.0
Overpriced
💰
STRONG SELL
Options are overpriced - Sell premium opportunity
Seller's Advantage:
Premium Collected
$20.00
Profit if Target Hits
$20.00
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for 1.2% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 37 | Volume: 9
Data as of: May 22, 2025
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
Timeframe Target Price Potential Return
30 Days $277.47 -0.3%
90 Days $275.58 -1.0%
6 Months $272.80 -2.0%
1 Year $267.23 -4.0%
2 Years EXTENDED $256.54 -7.8%
3 Years EXTENDED $246.28 -11.5%

More BIO Analysis

Why is BIO Moving? Buy or Sell BIO? BIO Full Analysis BIO Trendline Analysis
BIO Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$334.04 (+20.0%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$267.23 (+-4.0%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$187.06 (-32.8%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
56.9
Neutral
MACD Signal
Bullish
Trend
Uptrend
Money Flow (CMF)
-0.02

Key Fundamentals

P/E Ratio
10.01
Forward P/E
32.79
P/S Ratio (TTM)
2.91x
Fair
Revenue Growth (QoQ)
0.0%
Earnings Growth (QoQ)
-0.8%
Market Cap
$7,527M
Analyst Target
$321.25
52-Week High
$281.94
52-Week Low
$278.36

Options Activity

Alert Score
94/100
Classification
Strong Alert
Unusual Activity
84.0
IV Spike
+130.5%

Recommendation: Strong unusual activity detected. Review for potential entry.

Frequently Asked Questions

What is the BIO stock price prediction for 2026?

Based on our AI analysis, BIO is predicted to reach $267.23 by 2026, representing a potential 4.0% decrease from the current price of $278.36.

Is BIO stock a good buy right now?

Our analysis suggests BIO is a "HOLD" based on current technical and fundamental indicators. With a projected 4.0% downside, investors should consider their risk tolerance and investment horizon.

What is BIO 52-week high and low?

BIO has a 52-week high of $281.94 and a 52-week low of $278.36. The stock is currently trading 1.3% below its 52-week high.

What is the technical analysis for BIO?

BIO is currently in a uptrend trend. The RSI of 56.9 indicates the stock is trading in neutral territory. Traders should monitor support and resistance levels for potential entry points.

Where will BIO stock be in 3 years?

Our long-term projection estimates BIO could reach $246.28 by 2028, representing a 11.5% decline from current levels. Long-term predictions carry more uncertainty.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis